Rocket Pharmaceuticals's market cap is currently $1.16B. The company's EPS TTM is $-2.754; its P/E ratio is ―; Rocket Pharmaceuticals is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -7.10M	$ -6.27M	$ -5.37M	$ -1.15M	$ -426.00K
Operating Income	$ -259.66M	$ -224.34M	$ -167.25M	$ -134.30M	$ -76.15M
EBITDA	$ -236.62M	$ -213.69M	$ -161.72M	$ -131.59M	$ -71.14M
Net Income	$ -245.59M	$ -219.38M	$ -169.59M	$ -146.67M	$ -83.23M
Balance Sheet
Cash & Short-Term Investments	$ 373.18M	$ 356.39M	$ 388.74M	$ 482.72M	$ 304.12M
Total Assets	$ 566.34M	$ 551.81M	$ 497.02M	$ 590.82M	$ 372.12M
Total Debt	$ 25.04M	$ 22.87M	$ 22.60M	$ 61.70M	$ 47.45M
Net Debt	$ -30.86M	$ -117.65M	$ -210.09M	$ -235.40M	$ -137.93M
Total Liabilities	$ 73.77M	$ 62.12M	$ 42.30M	$ 87.31M	$ 64.82M
Stockholders' Equity	$ 492.57M	$ 489.69M	$ 454.72M	$ 503.52M	$ 307.30M
Cash Flow
Free Cash Flow	$ -211.39M	$ -186.76M	$ -128.88M	$ -103.70M	$ -87.93M
Operating Cash Flow	$ -194.92M	$ -178.14M	$ -121.16M	$ -74.64M	$ -64.66M
Investing Cash Flow	$ -98.07M	$ -69.33M	$ 18.85M	$ -96.59M	$ -39.01M
Financing Cash Flow	$ 208.40M	$ 155.29M	$ 37.68K	$ 282.99M	$ 177.79M

Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History

Income Statement >

Rocket Pharmaceuticals Debt to Assets

Balance Sheet >

Rocket Pharmaceuticals Cash Flow

Cash Flow >

Rocket Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing